TXNIP and pemphigus foliaceus: Dimethyl itaconate (DMI), a cell-permeable itaconate derivative synthesized in vitro, was reported to protect against PF via activating Nrf2 and inhibiting thioredoxin-interacting protein (TXNIP) expression, thereby restraining TXNIP-mediated FMD [141].